BBS-Bioactive Bone Substitutes (OHEL:BONEH) Total Liabilities : €5.51 Mil (As of Dec. 2023)

View and export this data going back to 2018. Start your Free Trial

What is BBS-Bioactive Bone Substitutes Total Liabilities?

BBS-Bioactive Bone Substitutes's Total Liabilities for the quarter that ended in Dec. 2023 was €5.51 Mil.

BBS-Bioactive Bone Substitutes's quarterly Total Liabilities declined from Dec. 2022 (€6.42 Mil) to Jun. 2023 (€6.37 Mil) and declined from Jun. 2023 (€6.37 Mil) to Dec. 2023 (€5.51 Mil).

BBS-Bioactive Bone Substitutes's annual Total Liabilities declined from Dec. 2021 (€6.87 Mil) to Dec. 2022 (€6.42 Mil) and declined from Dec. 2022 (€6.42 Mil) to Dec. 2023 (€5.51 Mil).

BBS-Bioactive Bone Substitutes Total Liabilities Historical Data

The historical data trend for BBS-Bioactive Bone Substitutes's Total Liabilities can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

BBS-Bioactive Bone Substitutes Total Liabilities Chart

BBS-Bioactive Bone Substitutes Annual Data

Trend

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Total Liabilities

Get a 7-Day Free Trial

6.75

6.61

6.87

6.42

5.51

BBS-Bioactive Bone Substitutes Semi-Annual Data
	Dec15	Dec16	Jun17	Dec17	Jun18	Dec18	Jun19	Dec19	Jun20	Dec20	Jun21	Dec21	Jun22	Dec22	Jun23	Dec23
Total Liabilities	Get a 7-Day Free Trial											6.87	7.14	6.42	6.37	5.51

BBS-Bioactive Bone Substitutes Total Liabilities Calculation

Total Liabilities are the liabilities that the company has to pay others. It is a part of the balance sheet of a company that shareholders do not own, and would be obligated to pay back if the company liquidated.

BBS-Bioactive Bone Substitutes's Total Liabilities for the fiscal year that ended in Dec. 2023 is calculated as

Total Liabilities	=	Total Current Liabilities	+	Total Noncurrent Liabilities
	=	Total Current Liabilities	+	(Long-Term Debt & Capital Lease Obligation	+	Other Long-Term Liabilities
	=	1.377	+	(3.951	+	0.177
	+	NonCurrent Deferred Liabilities	+	PensionAndRetirementBenefit)
	+	0	+	0)
	=	5.51

Total Liabilities	=	Total Assets (A: Dec. 2023 )	-	Total Equity (A: Dec. 2023 )
	=	10.613	-	5.108
	=	5.51

BBS-Bioactive Bone Substitutes's Total Liabilities for the quarter that ended in Dec. 2023 is calculated as

Total Liabilities	=	Total Current Liabilities	+	Total Noncurrent Liabilities
	=	Total Current Liabilities	+	(Long-Term Debt & Capital Lease Obligation	+	Other Long-Term Liabilities
	=	1.377	+	(3.951	+	0.177
	+	NonCurrent Deferred Liabilities	+	PensionAndRetirementBenefit)
	+	0	+	0)
	=	5.51

Total Liabilities	=	Total Assets (Q: Dec. 2023 )	-	Total Equity (Q: Dec. 2023 )
	=	10.613	-	5.108
	=	5.51

BBS-Bioactive Bone Substitutes Total Liabilities Related Terms

Thank you for viewing the detailed overview of BBS-Bioactive Bone Substitutes's Total Liabilities provided by GuruFocus.com. Please click on the following links to see related term pages.

BBS-Bioactive Bone Substitutes (OHEL:BONEH) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » BBS-Bioactive Bone Substitutes PLC (OHEL:BONEH) » Definitions » Total Liabilities

Comparable Companies

Traded in Other Exchanges

N/A

Address

Kiviharjunlenkki 6, Oulu, FIN, 90220

Website

http://www.bbs-artebone.fi

BBS-Bioactive Bone Substitutes PLC is a health technology company, that develops, designs, and manufactures bioactive bone-graft substitute implants. Its ortho-biological product ARTEBONE, which is based on tricalcium phosphate and a natural spectrum of bone proteins has the capability of bone regeneration.

BBS-Bioactive Bone Substitutes (OHEL:BONEH) Headlines

No Headlines